Literature DB >> 31470781

Long Non-Coding RNAs As Epigenetic Regulators in Cancer.

Asma Vafadar1, Zahra Shabaninejad2,3, Ahmad Movahedpour1,4, Soheila Mohammadi5,6, Sima Fathullahzadeh7, Hamid R Mirzaei8, Afshin Namdar9, Amir Savardashtaki1,3, Hamed Mirzaei10.   

Abstract

Long noncoding RNAs (lncRNAs) constitute large portions of the mammalian transcriptome which appeared as a fundamental player, regulating various cellular mechanisms. LncRNAs do not encode proteins, have mRNA-like transcripts and frequently processed similar to the mRNAs. Many investigations have determined that lncRNAs interact with DNA, RNA molecules or proteins and play a significant regulatory function in several biological processes, such as genomic imprinting, epigenetic regulation, cell cycle regulation, apoptosis, and differentiation. LncRNAs can modulate gene expression on three levels: chromatin remodeling, transcription, and post-transcriptional processing. The majority of the identified lncRNAs seem to be transcribed by the RNA polymerase II. Recent evidence has illustrated that dysregulation of lncRNAs can lead to many human diseases, in particular, cancer. The aberrant expression of lncRNAs in malignancies contributes to the dysregulation of proliferation and differentiation process. Consequently, lncRNAs can be useful to the diagnosis, treatment, and prognosis, and have been characterized as potential cancer markers as well. In this review, we highlighted the role and molecular mechanisms of lncRNAs and their correlation with some of the cancers. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Long non-coding RNAs; cancer; cell cycle regulation; epigenetics; genomic imprinting; mammalian transcriptome.

Mesh:

Substances:

Year:  2019        PMID: 31470781     DOI: 10.2174/1381612825666190830161528

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  22 in total

Review 1.  Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations.

Authors:  Xiaman Wang; Ying Shen; Rui Liu; Aili He
Journal:  Mol Biol Rep       Date:  2021-03-11       Impact factor: 2.316

2.  Pregnancy-associated changes in cervical noncoding RNA.

Authors:  Kristin D Gerson; Miriam J Haviland; Dayna Neo; Jonathan L Hecht; Andrea A Baccarelli; Kasey Jm Brennan; Alexandra E Dereix; Steven J Ralston; Michele R Hacker; Heather H Burris
Journal:  Epigenomics       Date:  2020-08-18       Impact factor: 4.778

3.  RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription.

Authors:  Jianjun Wang; Feng Huang; Yaxiang Shi; Qinghui Zhang; Song Xu; Yongliang Yao; Runqiu Jiang
Journal:  Gastric Cancer       Date:  2020-07-04       Impact factor: 7.370

Review 4.  Gastrointestinal cancer drug resistance: the role of exosomal miRNAs.

Authors:  Mahsa Salehi; Asma Vafadar; Seyyed Hossein Khatami; Mortaza Taheri-Anganeh; Omid Vakili; Amir Savardashtaki; Babak Negahdari; Parisa Naeli; Hamid Behrouj; Hassan Ghasemi; Ahmad Movahedpour
Journal:  Mol Biol Rep       Date:  2021-11-30       Impact factor: 2.316

Review 5.  Cardiac complications in inherited mitochondrial diseases.

Authors:  Mohaddeseh Behjati; Mohammad Reza Sabri; Masood Etemadi Far; Majid Nejati
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

6.  [Differential mRNA expression in C57BL/6 mice with bleomycin-induced pulmonary fibrosis and its association with LncRNA co-expression network].

Authors:  Xuefei Yu; Li Li; Linxin Zheng; Weifeng Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

Review 7.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

8.  Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.

Authors:  Lijun Yan; Chaosen Yue; Yingchen Xu; Xincen Jiang; Lijun Zhang; Jixiang Wu
Journal:  Med Sci Monit       Date:  2020-05-16

Review 9.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12

10.  Long non-coding RNA NEAT1/miR-338-3p axis impedes the progression of acute myeloid leukemia via regulating CREBRF.

Authors:  Song Feng; Na Liu; Xiaoguang Chen; Yufeng Liu; Jindou An
Journal:  Cancer Cell Int       Date:  2020-04-07       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.